SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?


To: mesaone who wrote (1052)6/12/1998 1:18:00 PM
From: Bill Wexler  Read Replies (1) | Respond to of 4634
 
Biotime is a fraud:

1) Biotime has repeatedly misrepresented clinical data.
2) Biotime has fraudulently promoted its stock.
3) Biotime management has effectively sold stock "out the back door" without filing S-4 by a sleazy method where Biotime stock has been used to collateralize large margin accounts.
4) Biotime has grossly overestimated the potential market for Hextend.